- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Lymphoma, Large B-Cell, Diffuse in United States
Total 4236 results
-
Duke UniversityCompletedDiffuse Large B-cell LymphomaUnited States
-
University of PennsylvaniaCompletedAcute Lymphocytic Leukemia | Diffuse Large Cell LymphomaUnited States
-
C. Babis AndreadisGlaxoSmithKline; University of California, San FranciscoCompletedDiffuse Large Cell Lymphoma Relapsed/RefractoryUnited States
-
ADC Therapeutics S.A.CompletedDiffuse Large B-cell Lymphoma Recurrent | Diffuse Large B-Cell Lymphoma RefractoryUnited States, United Kingdom, Italy, Switzerland
-
ImmunoVaccine Technologies, Inc. (IMV Inc.)Merck Sharp & Dohme LLCRecruitingRelapsed Diffuse Large B-cell Lymphoma | Refractory Diffuse Large B-cell LymphomaAustralia, Spain, United States, France, Hungary, New Zealand, Poland, Serbia, Canada, Romania
-
AmgenMerck Sharp & Dohme LLCCompletedRelapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)United States, Germany, Spain, Australia, Netherlands, France
-
National Cancer Institute (NCI)RecruitingHigh Grade B-Cell Lymphoma | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell LymphomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedCD30-Positive Diffuse Large B-Cell Lymphoma | CD30 Positive Primary Mediastinal Large B-cell Lymphoma | CD30-Positive Gray Zone LymphomaUnited States
-
Kite, A Gilead CompanyGenentech, Inc.CompletedRefractory Diffuse Large B Cell LymphomaUnited States
-
Medical College of WisconsinMidwest Athletes Against Childhood CancerNot yet recruitingLymphoma | Leukemia | Hodgkin Disease | CD30-Positive Diffuse Large B-Cell Lymphoma | CD30+ Anaplastic Large Cell Lymphoma | CD30+ Pleomorphic Large T-Cell Cutaneous Lymphoma | CD30+ Immunoblastic Large T-Cell Cutaneous LymphomaUnited States
-
Barbara Ann Karmanos Cancer InstituteWithdrawnRelapsed Diffuse Large B-cell LymphomaUnited States
-
TCR2 TherapeuticsCompletedFollicular Lymphoma | Acute Lymphoblastic Leukemia | Mantle Cell Lymphoma | Non Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | Primary Mediastinal Large B Cell LymphomaUnited States
-
Carevive Systems, Inc.CompletedFollicular Lymphoma | Diffuse Large B Cell LymphomaUnited States
-
Dana-Farber Cancer InstituteSanofi; Genzyme, a Sanofi CompanyTerminatedNon Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | High-grade B-cell LymphomaUnited States
-
Acerta Pharma BVActive, not recruitingActivated B-cell Diffuse Large B-Cell Lymphoma (ABC DLBCL)United States, United Kingdom
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingRecurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Recurrent Diffuse Large B-Cell... and other conditionsUnited States
-
ADC Therapeutics S.A.RecruitingRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaJapan, Belgium, France, Italy, Spain, United Kingdom, United States, Israel, Hungary, Brazil, Switzerland, Poland, Canada, Puerto Rico, Czechia, Netherlands, China, Mexico, Argentina, Chile, Turkey
-
Stanford UniversityTerminatedLymphoma, Non-Hodgkin | Diffuse Large B-cell Lymphoma (DLBCL) | Lymphoma, B-cell | Malignant Lymphoma, Non-HodgkinUnited States
-
GWT-TUD GmbHHoffmann-La RocheRecruitingRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-cell LymphomaGermany, Spain, United Kingdom, Austria
-
Anne Beaven, MDNovartisTerminatedDiffuse Large B-cell LymphomaUnited States
-
Jonsson Comprehensive Cancer CenterNational Institutes of Health (NIH)CompletedLymphoma | Lymphoma, Non-Hodgkin | Large B Cell Diffuse LymphomaUnited States, Germany
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell Lymphoma (DLBCL)United States
-
Kartos Therapeutics, Inc.RecruitingChronic Lymphocytic Leukemia | Non Hodgkin Lymphoma | Diffuse Large B Cell LymphomaBelgium, Korea, Republic of, United States, United Kingdom, Italy, Switzerland, Australia, France, Poland, Portugal, Czechia
-
Pharmacyclics LLC.CompletedDiffuse Large Cell B-lymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Transformed Non-Hodgkin Lymphoma | Richter Syndrome | Refractory Transformed Non-Hodgkin Lymphoma | Transformed Follicular Lymphoma to Diffuse Large B-Cell LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; National Cancer Institute (NCI); University of California... and other collaboratorsActive, not recruitingHodgkin's Lymphoma | Diffuse Large B-cell LymphomaUnited States
-
University of SouthamptonMerck Sharp & Dohme LLCRecruitingDiffuse Large B Cell LymphomaUnited Kingdom
-
University of WashingtonMerck Sharp & Dohme LLCActive, not recruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal Large B-Cell Lymphoma | Refractory Primary Mediastinal Large B-Cell LymphomaUnited States
-
Dipenkumar ModiGenmabRecruitingRelapsed Cancer | Refractory Cancer | Large Cell Lymphoma, DiffuseUnited States
-
Roswell Park Cancer InstituteRecruitingRecurrent Mantle Cell Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Chronic Lymphocytic Leukemia | Refractory Mantle Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma | Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell... and other conditionsUnited States
-
University of MiamiAstraZenecaTerminatedMarginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B Cell Lymphoma | Small Lymphocytic LeukemiaUnited States
-
Tessa TherapeuticsActive, not recruitingAnaplastic Large Cell Lymphoma | Diffuse Large B Cell Lymphoma | Peripheral T Cell Lymphoma | Extranodal NK/T-cell Lymphoma | Primary Mediastinal Large B-Cell Lymphoma (PMBCL)United States
-
Lapo AlinariRecruitingRecurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Refractory High Grade B-Cell Lymphoma With MYC... and other conditionsUnited States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...Not yet recruitingHodgkin Lymphoma | Non-Hodgkin Lymphoma | Peripheral T-cell Lymphoma | Anaplastic Large Cell Lymphoma, ALK-Positive | Anaplastic Large Cell Lymphoma, ALK-negative | CD30-Positive Diffuse Large B-Cell Lymphoma | Anaplastic Large Cell Lymphoma, T Cell and Null Cell TypeUnited States
-
Adicet Bio, IncEnrolling by invitationLymphoma, Follicular | Lymphoma, Non-Hodgkin | Lymphoma, Mantle-Cell | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Primary Mediastinal B-cell LymphomaUnited States
-
Novartis PharmaceuticalsActive, not recruitingDiffuse Large B-cell LymphomaSpain, Germany, Canada, Italy, Hong Kong, China, Japan, France, United States, Singapore
-
Memorial Sloan Kettering Cancer CenterJanssen Scientific Affairs, LLC; Xynomic Pharmaceuticals, Inc.Active, not recruitingMantle Cell Lymphoma | Diffuse Large B-cell LymphomaUnited States
-
M.D. Anderson Cancer CenterRecruiting
-
Masonic Cancer Center, University of MinnesotaActive, not recruitingNon Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | NHL | High-grade B-cell LymphomaUnited States
-
Duke UniversityActive, not recruitingDiffuse Large B Cell LymphomaUnited States, Japan, Italy, Korea, Republic of, Czechia, Singapore
-
SanofiCompletedDiffuse Large B-cell LymphomaBelgium, Israel, Spain, Czechia, Turkey, Italy, United States, Poland, United Kingdom
-
Northwestern UniversityNational Cancer Institute (NCI)RecruitingRecurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Recurrent... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedBurkitt Lymphoma | High-grade B-cell Lymphoma | Diffuse Large B-Cell Lymphoma (DLBCL) | T-cell/Histocyte-rich Large B-cell Lymphoma | Germinal Center B-cell Type (GCB)United States
-
Hoffmann-La RocheCompletedDiffuse Large B-cell Lymphoma | High-Grade B-cell LymphomaUnited States, Spain, Australia, Denmark
-
Acrotech Biopharma Inc.CompletedNon-Hodgkin's Lymphoma | Mantle Cell Lymphoma | Diffuse Large B-cell LymphomaUnited Kingdom, United States
-
CureTech LtdCompletedPrimary Mediastinal Large B-Cell Lymphoma | Lymphoma, Large Cell, Diffuse | Lymphoma, Mixed Cell, DiffuseUnited States, Israel, India
-
National Cancer Institute (NCI)TerminatedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Splenic Marginal Zone Lymphoma | Waldenström Macroglobulinemia | Testicular Lymphoma | Contiguous Stage II Adult Diffuse Large Cell Lymphoma | Noncontiguous Stage II Adult Diffuse... and other conditionsUnited States
-
Northwestern UniversityBristol-Myers Squibb; National Cancer Institute (NCI); AbbVieWithdrawnRichter Syndrome | Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma | Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma | Recurrent Transformed Chronic Lymphocytic Leukemia | Refractory Transformed Chronic Lymphocytic LeukemiaUnited States
-
Genentech, Inc.CompletedLymphocytic Leukemia, Chronic, Diffuse Large B-Cell LymphomaUnited States, Australia